Fellow OWCP shareholders keep asking things like, “When do you think we’ll hear any updates?” While I don’t know any specifics on when or what we’ll hear, I wanted to make a list of things I expect to hear updates on over the next month (or two).

Final Psoriasis Topical Cream Study, Efficacy Results:

In a video interview with CFN, Dr. Yehuda Baruch of OWC stated (around the 3 minute mark) there were two on-going studies — both of which should be completed by the end of April “and then we can have the results published” (around the 3:30 mark).

I have no idea how long it takes to officially prepare, write-up, and publish results after a medical study — but I imagine we could hear something before mid-May. That’s purely a guess on my part.

I wouldn’t be surprised if we see an update of the Patent process sometime towards end of May or early June either. Perhaps the official “Patent Approved” statement.

Other Skin Conditions:

Remember in the 8K on March 20th when Mordechai Bignitz, has directed OWC’s scientific team to submit an operating plan within 60 to 90 days to conduct double-blind efficacy tests of our cannabinoid-based topical cream on other skin disorders and conditions?  Yeah. That’s as soon as May 19th.

I don’t know about you, but I can’t wait to hear what kind of skin disorders and conditions they feel they have a solid Topical Cream for. Dr. Rozenblat was an asset on that, I’m sure.

Partnership, Joint Venture:

We know from the 8K released on April 8th, 2017 that OWCP had world-wide interest from “leading international scientific institutions” in countries like Germany, the Czech Republic, Hungary, and more. We also know they reported they were “currently in negotiations for scientific and marketing cooperation agreements”.

What I personally expect at some point, hopefully within early May as well, is an 8K that talks about an executed agreement/partnership/joint venture between OWCP and another, larger company to help distribute their product(s) throughout Europe, Germany, etc. I assume this agreement will show OWCP earning a nice royalty.

Update on Sublingual Tablet:

There was confusion amongst some investors on the Sublingual Tablet due to the 10K talking about “the agreement was terminated” before the start of 2016. But, again, that was just an agreement between OWCP and G.C. Group, Ltd. The “proof of concept” for the Sublingual Tablet was already developed and even in the most recent update of the Investor Presentation at OWCpharma.com, the tablet is still listed as READY.

So, I remain hopeful that we can see an update on when to expect the Tablet. Maybe the negotiations included the Sublingual Tablet. Time will tell. I know I’ll “stay tuned” and remain patient.

If you look at their Timeline on the 10K, you’ll see it specifically says “Fibromyalgia” with a status of “Drafted a clinical trial protocol synopsis”. That tells me an update is due in the near future too.

Multiple Myeloma Research & Study:

Again, from the 10K, they have the status listed as “Intend to commence a clinical study in the third quarter of 2017” and “Drafted a clinical trial protocol synopsis, which we believe will assist us in preparing an application for orphan status designation”

Both of these statements tell me we should have another update within Quarter 2 on this (likely) game changing research. After all, they’ve already reported, “The results indicated a 100% mortality rate of myeloma cells in 80% of the cultured cells within a 24 to 48-hour period, and highlight the potential abilities of cannabis oil extract to fight multiple myeloma cancer cells. We believe that the results of this study indicate a potential to develop a more effective treatment for multiple myeloma than standard therapies.”



There’s just too much going on. There are many, many updates that could come at any time. This, again, is why I can’t risk selling anything in hopes of flipping. (I’m not a day trader and cannot watch the trading action throughout the day).

As always, I urge you to decide for yourself if you want to Buy more, Sell some or all, or Hold all. I know what I’m doing. This is the first and only OTC stock I’ve held for more than 3 months and due to the pipeline and the DD — I can’t imagine selling much (if any) before the Fall of 2017. Call me crazy all you want, but I suspect in the end… My patience will aid in making me crazy profits. 🙂

(The occasional basher has called me crazy since OWCP was trading at $0.05 and I was saying $0.20 is coming soon.)